文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

纯合p.Leu813Pro功能获得性NLRP1变异在两名同胞中导致严重程度不同的表型

A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblings.
PubMed 文献 · Br J Dermatol · 2023-01-01

一项 trio 外显子组测序研究在两名姐妹中发现共有的纯合NLRP1 p.Leu813Pro变异,妹妹表现为泛发性炎性结节伴角质栓、临床类似多发性角化棘皮瘤,姐姐表现为家族性慢性苔藓样角化病。重组表达该变异可激活NLRP1炎症小体,导致ASC斑点形成和IL-1β释放。作者认为这是同一同胞中NLRP1变异导致不同严重程度临床谱的首例报告,IL-5和IL-17可能为疾病修饰因素并可作为治疗靶点。

要点

  • 两名姐妹共享纯合NLRP1 p.Leu813Pro变异,但皮肤表现严重程度不同。
  • 该变异可激活NLRP1炎症小体,促进ASC斑点形成和IL-1β释放。
  • 作者认为IL-5和IL-17可能为疾病修饰因素并可考虑作为治疗靶点。

核心结论

  • 据作者所知,这是首例报告NLRP1变异在同一同胞中导致不同严重程度临床谱。
  • IL-5和IL-17是重症患者炎性皮损中主要表达的细胞因子,可能被视为疾病修饰因素,并因此可考虑作为治疗靶点。

研究设计与样本

  • 研究对两名临床谱严重程度不同的姐妹进行了 trio 外显子组测序,并重组表达p.Leu813Pro以评估其对炎症小体组装的影响,同时进行外显子组测序和RNA-Seq以识别可能修饰皮肤表现严重程度的因素。

主要发现

  • 妹妹表现为泛发性炎性结节伴角质栓、临床类似多发性角化棘皮瘤,姐姐表现为家族性慢性苔藓样角化病的表现。
  • 变异p.Leu813Pro触发NLRP1炎症小体激活,导致ASC斑点形成和白细胞介素(IL)-1β释放。
  • 受累更重的姐妹携带若干与特应性和银屑病相关的额外基因组变异,而其同胞未携带。
  • IL-5和IL-17是驱动重症同胞皮肤显著炎症的主要细胞因子。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A trio exome sequencing study identified a previously unreported NLRP1 gene variant resulting in a p.Leu813Pro substitution of the LRR (leucine-rich repeats) domain of the NLRP1 protein (NACHT, LRR and PYD domains-containing protein 1). This homozygous mutation was shared by two sisters with different clinical presentation: the younger sister had generalized inflammatory nodules with keratotic plugs, clinically resembling multiple keratoacanthomas, while the older had manifestations of familial keratosis lichenoides chronica. OBJECTIVES: To analyse the consequences of this NLRP1 variant in two siblings with a different clinical spectrum of severity. METHODS: To demonstrate the pathogenicity, p.Leu813Pro was recombinantly expressed, and its effect on inflammasome assembly was assessed. Exome sequencing and RNA-Seq were performed to identify factors with potentially modifying effects on the severity of the skin manifestation between each sibling. RESULTS: The variant p.Leu813Pro triggered activation of the NLRP1 inflammasome leading to ASC (apoptosis-associated speck-like protein containing a CARD) speck formation and interleukin (IL)-1β release. The more severely affected sister had several additional genomic variants associated with atopy and psoriasis that were not present in her sibling. IL-5 and IL-17 emerged as dominant cytokines driving prominent inflammation in the skin of the severely affected sibling. CONCLUSIONS: To the best of our knowledge, this is the first report of a NLRP1 variant that leads to a different clinical spectrum of severity within the same sibship. IL-5 and IL-17 were the main cytokines expressed in the inflammatory lesions of the severely affected patient and might be regarded as disease modifying factors, and therefore may be considered as therapeutic targets.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Li M, Lay K, Zimmer A, et al. A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblings. Br J Dermatol. 2023. PMID: 36763876. doi:10.1093/bjd/ljac039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。